Close Menu

stock downgrade

NEW YORK (GenomeWeb News) – Citing pricing pressures in the whole-genome sequencing space and Complete Genomics' rising operating expenses, investment bank William Blair today downgraded the Mountain View, Calif.-based firm's stock to Market Perform.

NEW YORK (GenomeWeb News) – Mizuho Securities today downgraded Life Technologies and Thermo Fisher Scientific on concerns about an uncertain academic spending environment.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Investment bank Mizuho today lowered estimates on Qiagen, citing concerns about competition, higher cost assumptions, and an unsettled European market.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.